(599h) Towards A Treatment Of Human Caries Using Ultrafine Bioactive Glass Nanoparticles | AIChE

(599h) Towards A Treatment Of Human Caries Using Ultrafine Bioactive Glass Nanoparticles

Authors 

Vollenweider, M. - Presenter, Swiss Federal Institute of Technology (ETH Zurich)
Brunner, T. J. - Presenter, Swiss Federal Institute of Technology (ETH Zurich)
Knecht, S. - Presenter, Swiss Federal Institute of Technology (ETH Zurich)
Zehnder, M. - Presenter, University of Zurich Center of Dental Medicine
Imfeld, T. - Presenter, University of Zurich Center of Dental Medicine


Bioactive glasses are known to form a tight bond with living bone [1] and can be applied for bone repair and regeneration. They also play an important role in dental applications and have been proposed to act as remineralization agents for dental applications [2]. In this study, nanoparticles of bioactive glass produced by flame spray synthesis [3] were tested for their remineralization capabilities in vitro. After artificial demineralization with EDTA, human dentin was treated with 20-50 nm size bioactive glass nanoparticles or a micrometer-sized, commercial reference material (Perioglass) for up to 30 days. The degree of remineralization was measured using quantitative gravimetric methods (thermogravimetry, element analysis) and element sensitive scanning electron microscopy imaging to detect new mineral precipitated on or within the demineralized tooth matrix. After treatment with bioactive glass nanoparticles for 10 or 30 days, a pronounced increase in mineral content of the dentin samples suggested a rapid remineralization. The mechanical properties of the remineralized teeth were well below the stability of natural dentin. It is suggested that this lack of mechanical reconstitution may be attributed to an imperfect arrangement of the newly deposited mineral within the demineralized tooth matrix [4].

Nevertheless, the substantially higher remineralization rate induced by nanometer-sized versus micrometric bioactive glass particles corroborated the importance of particle size in clinical bioglass applications.

References:

[1] L.L. Hench, J. Biomed. Mat. Res. 5:117-41 (1971).

[2] H. Yli-Urpo, M. Narhi, T. Narhi, Biomaterials, 26(30):5934-5941 (2005).

[3] T.J. Brunner, R.N. Grass, W.J. Stark, Chem. Commun., 13, 1384-86 (2006).

[4] M. Vollenweider, T.J. Brunner, S. Knecht, R.N. Grass, M. Zehnder, T. Imfeld, W.J. Stark, Acta Biomater., accepted (2007).